Claims for Patent: 9,205,000

Summary for Patent: 9,205,000

Title:	Reduced-pressure treatment systems and methods employing debridement mechanisms
Abstract:	Reduced-pressure treatment systems and methods are disclosed that employ debridement mechanisms to remove unwanted tissue. In one instance, a reduced-pressure treatment system for treating a tissue site on a patient includes a manifold member for distributing reduced pressure to the tissue site, a support member for disposing proximate the tissue site and the manifold, and a debridement mechanism coupled to the support member. The debridement mechanism is for debriding the tissue site. The system further includes a sealing drape for placing over the tissue site and manifold member. The sealing drape is operable to form a fluid seal over the tissue site and manifold member. The system also includes a reduced-pressure subsystem for delivering a reduced pressure to the sealing drape. The system may further include a chemical-debridement subsystem. Other systems, manifolds, and methods, are disclosed.
Inventor(s):	Seegert; Charles Alan (Irving, TX), Wilkes; Robert Peyton (San Antonio, TX)
Assignee:	KCI Licensing, Inc. (San Antonio, TX)
Application Number:	13/931,353
Patent Claims:	1. A manifold member for debriding a tissue site on a patient, the manifold member comprising: a manifold material formed from a porous material that contracts in response to reduced pressure; a support member coupled to the manifold material; and a pincer including a first blade and a second blade, each blade having a proximal end coupled to the support member and a distal end for positioning at the tissue site, the distal ends of the first and second blades being movable for debriding the tissue site in response to the manifold material when contracting; wherein the distal ends of the first blade and the second blade move between an open position and a closed position under the influence of the reduced pressure. 2. The manifold member of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site. 3. The manifold member of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the chemical-debridement subsystem comprises a debriding chemical reservoir in fluid communication with the sealing drape whereby the debriding chemical is delivered to the tissue site. 4. The manifold member of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae. 5. The manifold member of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata. 6. The manifold member of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae. 7. The manifold member of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata. 8. The manifold member of claim 1, further comprising a chemical-debridement subsystem for delivering a debriding chemical to the tissue site, wherein the debriding chemical is a chemical selected from the group consisting of: collagenase, ficin, pepsin, trypsin, chymotrypsin, papain and elastase. 9. A method for debriding a tissue site on a patient, the method comprising: placing a manifold member formed from a porous material that contracts response to reduce pressure proximate the tissue site, wherein the manifold member comprises a support member and a pincer including a first blade and a second blade, each blade having a proximal end coupled to the support member and a distal end for positioning at the tissue site, the distal ends being movable for debriding the tissue site in response to the manifold member when contracting; disposing a sealing drape over the manifold member and the patient's epidermis; forming a fluid seal between the sealing drape and the patient's epidermis to form a fluid seal over the tissue site for application of reduced pressure to the manifold member; and providing a reduced pressure to the manifold member whereby the distal ends of the first blade and the second blade move between an open position and a closed position under the influence of the reduced pressure. 10. The method of claim 9, further comprising introducing a debriding chemical to the tissue site. 11. The method of claim 9, further comprising introducing a debriding chemical to the tissue site and wherein the debriding chemical is one or more enzymes isolated from insect larvae. 12. The method of claim 9, further comprising introducing a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata. 13. The method of claim 9, further comprising introducing a debriding chemical to the tissue site, and wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae. 14. The method of claim 9, further comprising introducing a debriding chemical to the tissue site, wherein the debriding chemical is one or more synthetic analogues of one or more enzymes isolated from insect larvae, and wherein the larvae are larvae from Lucilia sericata. 15. The method of claim 9, further comprising introducing a debriding chemical to the tissue site, wherein the debriding chemical is one or more enzymes isolated from insect larvae, and wherein the debriding chemical is a chemical selected from the group consisting of: collagenase, ficin, pepsin, trypsin, chymotrypsin, papain and elastase. 16. The method of claim 9, further comprising introducing a debriding chemical to the tissue site, and flushing the tissue site. 17. A method of manufacturing a manifold member for treating a tissue site on a patient, the method comprising: forming a manifold member for placing over a tissue site, the manifold member having a support member; coupling a debridement mechanism to the support member; and wherein the debridement mechanism is configured to debride a tissue site under the influence of reduced pressure. 18. The method of claim 17, wherein the debridement mechanism comprises a debridement implement.

Details for Patent 9,205,000

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2029-12-16